Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › (S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations

(S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations

US Patent 10577348 · Granted Mar 3, 2020

Estimated economic value: $158,257,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods of encoding BNPL transactions for terminal devices2025
Crystalline and salt forms of PPAR agonist compounds2024
Accelerometer contact microphones and methods thereof2023
Application curation2023
Crystalline and salt forms of PPAR agonist compounds2022
Mobility of user applications across cloud infrastructures2022
(S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,22021
Application curation2021
Crystalline and salt forms of PPAR agonist compounds2021
(S)-N-(3-6-isopropoxypyridin-3-3YL)-1H-indazol-5-yl)-1-(2-(4-4(1-methyl-1H-1,2,42020
Process for preparing formulations for gastrointestinal-targeted therapies2020
Sustained release formulation and tablets prepared therefrom2019